ETAHX
Price
$40.98
Change
+$0.30 (+0.74%)
Updated
Oct 6 closing price
Net Assets
1.37B
FSPHX
Price
$28.17
Change
+$0.33 (+1.19%)
Updated
Oct 3 closing price
Net Assets
5.96B
Interact to see
Advertisement

ETAHX vs FSPHX

Header iconETAHX vs FSPHX Comparison
Open Charts ETAHX vs FSPHXBanner chart's image
Eventide Healthcare & Life Sciences A
Price$40.98
Change+$0.30 (+0.74%)
VolumeN/A
Net Assets1.37B
Fidelity Select Health Care
Price$28.17
Change+$0.33 (+1.19%)
VolumeN/A
Net Assets5.96B
ETAHX vs FSPHX Comparison Chart in %
View a ticker or compare two or three
VS
ETAHX vs. FSPHX commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETAHX is a StrongBuy and FSPHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 5.96B vs. ETAHX (1.37B). FSPHX pays higher dividends than ETAHX: FSPHX (0.02) vs ETAHX (0.00). ETAHX was incepted earlier than FSPHX: ETAHX (13 years) vs FSPHX (44 years). ETAHX (1.57) is less costly to investors than FSPHX (0.63). ETAHX is a more actively managed with annual turnover of: 71.00 vs. FSPHX (40.00). FSPHX has a lower initial minimum investment than ETAHX: FSPHX (0) vs ETAHX (1000). ETAHX annual gain was more profitable for investors over the last year : 17.20 vs. FSPHX (-10.39). ETAHX (-13.72) and FSPHX (-13.76) have equivalent 5 years return.
ETAHXFSPHXETAHX / FSPHX
Total Expense Ratio1.570.63249%
Annual Report Gross Expense Ratio1.570.63249%
Fund Existence13 years44 years-
Gain YTD26.3353.376780%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.37B5.96B23%
Annual Yield % from dividends0.000.02-
Returns for 1 year17.20-10.39-166%
Returns for 3 years36.107.09509%
Returns for 5 years-13.72-13.76100%
Returns for 10 years93.8336.17259%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CGIIX53.26N/A
N/A
Calamos Growth & Income I
FAGOX210.09N/A
N/A
Fidelity Advisor Growth Opps M
SZCCX40.58N/A
N/A
DWS Small Cap Core C
MNOZX37.36N/A
N/A
Manning & Napier Overseas Series Z
LFVCX27.74N/A
N/A
Lord Abbett Focused Small Cap Value C